Article
Drug classes affecting intracranial aneurysm risk: genetic correlation and Mendelian randomization
2023-10-25
Abstract excerpt
<h4>Abstract and key words</h4> <h4>Background</h4> There is no non-invasive treatment option to prevent aneurysmal subarachnoid hemorrhage (ASAH) caused by intracranial aneurysm (IA) rupture. We aimed to identify drug classes that may affect liability to IA using a genetic approach. <h4>Methods</h4> We obtained genome-wide association summary statistics for unruptured IA (N=2,140 cases), ASAH (N=5,140 cases), and...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5f0cd515-0cd5-52d6-be45-493530d85dd7
- DOI
- 10.1101/2023.10.23.23297443
